How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Hydroxypropyl-β-Cyclodextrin Market
- By Application: Pharmaceuticals, Food and Beverages, Cosmetics and Personal Care, Agriculture, Environmental Remediation
- By Form: Powder, Liquid Solution
- By Purity Grade: Pharmaceutical Grade, Food Grade, Technical Grade
- By End-Use Industry: Pharmaceutical Manufacturing, Food Processing, Cosmetic Formulation, Agricultural Chemicals, Environmental Services
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pharmaceuticals leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Hydroxypropyl-β-Cyclodextrin Market report
A complete, evidence-based study - 11 chapters and 114 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Jungbunzlauer Suisse AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Wacker Chemie AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Roquette Frères
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Tosoh Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cyclolab Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ashland Global Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Ingredion Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Cargill
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BASF SE
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Mitsubishi Chemical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Dalian East New Materials Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Shandong Binzhou Zhiyuan Biotechnology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Ningbo Tianyi Chemical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hangzhou Tianyuan Biochemical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Suzhou Xiandai Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pharmaceuticals49.1
- Food and Beverages14.8
- Cosmetics and Personal Care10.1
- Agriculture15.4
- Environmental Remediation10.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Jungbunzlauer Suisse AG22.1
- Wacker Chemie AG12.9
- Roquette Frères10.8
- Tosoh Corporation7.8
- Cyclolab Ltd.7.1
- Ashland Global Holdings Inc.11.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe21.7
- Asia Pacific19.6
- Latin America14.3
- Middle East and Africa10.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Jungbunzlauer Suisse AG | 98 | 95 | 86 | 85 | 84 | 81 | 88 |
| Wacker Chemie AG | 91 | 88 | 71 | 83 | 74 | 80 | 81 |
| Roquette Frères | 81 | 87 | 84 | 72 | 80 | 77 | 80 |
| Tosoh Corporation | 61 | 58 | 63 | 82 | 73 | 62 | 67 |
| Cyclolab Ltd. | 71 | 55 | 52 | 54 | 52 | 69 | 59 |
| Ashland Global Holdings Inc. | 46 | 63 | 54 | 52 | 55 | 52 | 54 |
| Ingredion Incorporated | 50 | 48 | 52 | 50 | 45 | 51 | 49 |
| Cargill | 40 | 45 | 39 | 57 | 54 | 57 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Jungbunzlauer Suisse AG
- Wacker Chemie AG
- Roquette Frères
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Jungbunzlauer Suisse AG | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Wacker Chemie AG | ✓ | ◐ | ◐ | ◐ | − | ✓ |
| Roquette Frères | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Tosoh Corporation | − | ◐ | ◐ | ◐ | − | − |
| Cyclolab Ltd. | ◐ | − | − | − | ◐ | ◐ |
| Ashland Global Holdings Inc. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Ingredion Incorporated | ◐ | − | − | − | ◐ | − |
| Cargill | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Application in North America, then scale across Hydroxypropyl-β-Cyclodextrin Market — a $472M beachhead inside a $8.33B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Pharmaceuticals
Best fit — highest urgency & budget in Application.
Food and Beverages
Strong fit — clear ROI and a fast path to value.
Cosmetics and Personal Care
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Purity Grade
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Hydroxypropyl-β-Cyclodextrin Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Hydroxypropyl-β-Cyclodextrin Market is a durable-growth opportunity — $4.05B by 2033, compounding at 9.8%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Hydroxypropyl-β-Cyclodextrin Market — a $7.96B market by 2033. Plan: grow share from 7.4% to 15.7%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 15.7% | On track |
| Revenue | $633M | $1.25B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 34.2% | 45.1% | At risk |
| Customer retention | 86.1% | 93.1% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $160M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAhead
Sales deck · value proposition
Win the Hydroxypropyl-β-Cyclodextrin Market conversation — a $9.66B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Hydroxypropyl-β-Cyclodextrin Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Hydroxypropyl-β-Cyclodextrin Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →PAG Synthetic Lubricants Market
Market size, share, segmentation and regional forecast.
$492M market · 2025 base year
View reportPaint Spraying Units Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportHydroxypropyl Bispalmitamide MEA Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportHydroxypivalyl Hydroxypivalate (HPHP) Market
Market size, share, segmentation and regional forecast.
$668M market · 2025 base year
View reportHydroxyphenyl Propamidobenzoic Acid Market
Market size, share, segmentation and regional forecast.
$762M market · 2025 base year
View reportHydroxyphenoxy Propionic Acid (D-HPPA) Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportHydroxynitrile Lyase Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportHydroxymethyl Polystyrene Resin Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportHydroxymethylferrocene Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportHydroxyl Terminated Silicone Oil Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportPentachloropyridine Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportHydroxyl Terminated Poly Butadiene Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy